Recruiting Atopic Dermatitis Studies in Alpharetta
A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)
The purpose of this study is to evaluate how well JNJ-95475939 works as compared to placebo in participants with moderate to severe atopic dermatitis....
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
The purpose of this study is to assess the efficacy and safety of Afimkibart (also known as RO7790121) in participants with moderate to severe atopic dermatitis (AD)....
About Atopic Dermatitis Clinical Trials in Alpharetta
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Alpharetta, GA. These studies are seeking a combined 400 participants. Research is being sponsored by Janssen Research & Development, LLC, Hoffmann-La Roche. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Alpharetta — FAQ
Are there atopic dermatitis clinical trials in Alpharetta?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Alpharetta, GA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Alpharetta?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Alpharetta research site will contact you about next steps.
Are clinical trials in Alpharetta free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Alpharetta studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Alpharetta are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov